Function of uric acid transporters and their inhibitors in hyperuricaemia

H Sun, Y Wu, H Bian, H Yang, H Wang… - Frontiers in …, 2021 - frontiersin.org
Disorders of uric acid metabolism may be associated with pathological processes in many
diseases, including diabetes mellitus, cardiovascular disease, and kidney disease. These …

Uric acid participating in female reproductive disorders: a review

J Hu, W Xu, H Yang, L Mu - Reproductive Biology and Endocrinology, 2021 - Springer
Uric acid (UA) is the end metabolic product of purine metabolism. Early on, UA was
considered to be a metabolite with a certain antioxidant capacity. As research has …

The prevalence of hyperuricemia and its correlates among adults in China: results from CNHS 2015–2017

W Piao, L Zhao, Y Yang, H Fang, L Ju, S Cai, D Yu - Nutrients, 2022 - mdpi.com
This study aimed to investigate the prevalence of hyperuricemia (HUA) and associated risk
factors in Chinese adults aged 18 to 59 years. All the data were collected from the China …

Association between prenatal exposure to PFAS and fetal sex hormones: are the short-chain PFAS safer?

M Nian, K Luo, F Luo, R Aimuzi, X Huo… - Environmental …, 2020 - ACS Publications
Epidemiologic evidence regarding the effects of in utero exposure to per-and polyfluoroalkyl
substances (PFAS), particularly short-chain PFAS, on fetal reproductive hormones is limited …

Metabonomic analysis of follicular fluid in patients with diminished ovarian reserve

J Li, Z Zhang, Y Wei, P Zhu, T Yin, Q Wan - Frontiers in Endocrinology, 2023 - frontiersin.org
Background Ovarian reserve is an important factor determining female reproductive
potential. The number and quality of oocytes in patients with diminished ovarian reserve …

Serum uric acid/creatinine ratio and free androgen index are synergistically associated with increased risk of polycystic ovary syndrome in obese women

MM El-Eshmawy, A Ibrahim, R Bahriz… - BMC Endocrine …, 2022 - Springer
Background Features of metabolic syndrome such as abdominal obesity, insulin resistance,
hypertension and dyslipidemia are commonly encountered in polycystic ovary syndrome …

Lowering and raising serum urate levels: off-label effects of commonly used medications

N Leung, K Yip, MH Pillinger, M Toprover - Mayo Clinic Proceedings, 2022 - Elsevier
Drug-induced hyperuricemia and gout present an increasingly prevalent problem in clinical
practice. Herein, we review the urate-lowering or urate-raising effects of commonly used …

Efficacy of canagliflozin versus metformin in women with polycystic ovary syndrome: A randomized, open‐label, noninferiority trial

M Cai, X Shao, F Xing, Y Zhang, X Gao… - Diabetes, Obesity …, 2022 - Wiley Online Library
Objectives To determine the safety and efficacy of canagliflozin in comparison to metformin
in polycystic ovary syndrome (PCOS) patients with insulin resistance (IR). Methods A single …

Correlation between serum uric acid and body fat distribution in patients with polycystic ovary syndrome

Y Zhang, M Cai, D Dilimulati, Z Lin, H Sun… - Frontiers in …, 2022 - frontiersin.org
Objective This study aims to investigate the correlation between serum uric acid levels and
body fat distribution in patients with polycystic ovary syndrome (PCOS). Methods Between …

Elevated serum uric acid level is associated with adverse reproductive outcomes in women with polycystic ovary syndrome undergoing in vitro fertilization or …

H Yang, G Wang, C Liu, L Ding, Y Li, Y Chen… - American Journal of …, 2023 - Elsevier
Background Serum uric acid levels are elevated in polycystic ovary syndrome, however, the
relationship between serum uric acid level and reproductive outcomes in women with …